The Christian Doppler Laboratory for Personalized Immunotherapy aims to provide a comprehensive 360° biomarker including various tissue-based, blood-based and radiology-based information of a particular patient for prediction of response to immune checkpoint-inhibition.
Our Vision: Individual Immunotherapy for each Individual
Immunotherapy of cancer represents a major breakthrough in oncology as long-term disease control can be achieved in some patients even in advanced disease stages. Immune checkpoint inhibitors activate the patient’s own immune system in order to enhance the anti-tumor immune reaction. However, only a fraction of patients responds to the currently available immunotherapies, while a clinically relevant fraction presents with primary resistance. Biomarkers reliably predicting which patients respond to immune checkpoint inhibitors are therefore urgently needed.
- Matthias Preusser
Principle Investigator of the Christian Doppler Laboratory for Personalized Immunotherapy
matthias.preusser@meduniwien.ac.at
PubMed - Anna Bergmeister-Berghoff
Senior-Post Doc
anna.bergmeister-berghoff@meduniwien.ac.at
PubMed - Birgit Fendl
Post-Doc
birgit.fendl@meduniwien.ac.at
PubMed - Erwin Tomasich
Wissenschaftlicher Mitarbeiter
erwin.tomasich@meduniwien.ac.at
PubMed - Angelika Starzer
MD
angelika.starzer@meduniwien.ac.at
PubMed - Carina Peischl
PhD Student
carina.peischl@meduniwien.ac.at - Christina Paiato
Technician
christina.paiato@meduniwien.ac.at - Katalin Pinter
Administration
katalin.pinter@meduniwien.ac.at - Andreas Kienzle
Master Student
andreas.kienzle@meduniwien.ac.at
- Markus Raderer
Division of Oncology, Department of Medicine I
markus.raderer@meduniwien.ac.at - Thorsten Füreder
Division of Oncology, Department of Medicine I
thorsten.fuereder@meduniwien.ac.at - Barbara Kiesewetter-Wiederkehr
Division of Oncology, Department of Medicine I
barbara.kiesewetter-wiederkehr@meduniwien.ac.at - Leonhard Müllauer
Department of Pathology
leonhard.muellauer@meduniwien.ac.at - Christoph Bock
CeMM and Institute of Artificial Intelligence and Decision Support
christoph.bock@meduniwien.ac.at - Klaus Schmetterer
Department of Laboratory Medicine
klaus.schmetterer@meduniwien.ac.at - Harald Esterbauer
Department of Laboratory Medicine
harald.esterbauer@meduniwien.ac.at - Marius Mayerhöfer
Department of Biomedical Imaging and Image-guided Therapy
marius.mayerhoefer@meduniwien.ac.at - Georg Langs
Department of Biomedical Imaging and Image-guided Therapy
georg.langs@meduniwien.ac.at - Michael Weber
Department of Biomedical Imaging and Image-guided Therapy
michael.weber@meduniwien.ac.at - Helmut Prosch
Department of Biomedical Imaging and Image-guided Therapy
helmut.prosch@meduniwien.ac.at
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
LAG-3 expression in the inflammatory microenvironment of glioma
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
We are constantly looking to strengthen our team.
Therefore, applications are highly welcome.
Please send your CV and motivation letter to:
katalin.pinter@meduniwien.ac.at
Funding
The Christian Doppler Laboratory for Personalized Immunotherapy is supported by the funding program of the Christian Doppler Association in collaboration with Roche Austria.